CytoChip Inc.

CytoChip Inc. is a diagnostic device manufacturer specializing in point-of-care hematology testing. The company's flagship product, CitoCBC, is a cartridge-based Complete Blood Count (CBC) analyzer granted CLIA Waived status by the FDA, enabling non-laboratory personnel to perform accurate CBC testing in diverse healthcare settings including clinics, pharmacies, and home care environments. CitoCBC utilizes the company's proprietary OneChip microfluidics technology, which integrates micro-sized fluidics into disposable test cartridges containing built-in reagents. The platform requires only one drop of blood (finger prick or venous), delivers results in minutes, incorporates automated quality control, and requires no maintenance. Cartridges are stable at room temperature and require minimal user training. The company is expanding its product portfolio beyond CBC to include additional routine clinical tests, such as CitoPRP (Platelet-Rich Plasma preparation). CytoChip operates offices in the US (Irvine, California headquarters) and internationally, with distribution through Henry Schein in the US market. The founding team includes PhD engineers and scientists with expertise in microfluidics and clinical diagnostics. The company's OneChip technology emphasizes accuracy, reliability, minimal sample volume requirements, and ease of use for non-specialist operators across multiple care settings.